LATEST ALERTS
IHDC
US vape store survey, 2022 – IHDC and CBD product diversification
20th March 2023 - Market reports |
This report analyses the trends and changes in the US vape store channel concerning CBD and intoxicating hemp-derived cannabinoids (IHDCs)
CBD and IHDC online retailer database
17th March 2023 - Market data |
CannIntelligence’s online retailer database provides information on the CBD and intoxicating hemp-derived cannabinoid (IHDC) industries.
Bill prohibiting sale of hemp-derived toxic substances passes Senate…
17th March 2023 - Daily news alerts | Arkansas, North America, United States |
Supreme Court dismisses IHDC retailers’ lawsuit…
16th March 2023 - Daily news alerts | Georgia US, North America, United States |
Relaxation beats intoxication – IHDC sales aren’t just about getting high
15th March 2023 - News analysis |
HHC is the most popular intoxicating hemp-derived cannabinoid (IHDC) in Europe, while delta-8 THC remains top in the US, according to CannIntelligence analysts
A European country analysis of intoxicating hemp-derived cannabinoids
23rd January 2023 - Regulatory reports |
CannIntelligence has analysed regulations and contacted authorities in the majority of European countries to determine the legality of IHDCs. This report presents our findings
An overview of intoxicating hemp-derived cannabinoids in Europe
2nd January 2023 - Regulatory reports |
This report examines the basic regulatory framework for the most popular IHDC product categories and identifies the IHDC product that is most likely to be allowed in Europe
The question of semi-synthetics – HHC comes under scrutiny by EU authorities
29th December 2022 - News analysis |
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has begun the process of collecting data and evaluating the risk posed by hexahydrocannabinol (HHC) and other semi-synthetic cannabinoids
Which US states allow the sale of intoxicating hemp-derived cannabinoids in dispensaries?
16th August 2022 - Regulatory reports |
This report examines which US states allow the sale of intoxicating hemp-derived cannabinoid (IHDC) products in licensed dispensaries and which states have dispensaries offering them – regardless of whether they are permitted – to demonstrate the states that effectively deter IHDC sales in dispensaries
US regulatory trends on intoxicating hemp-derived cannabinoids
21st June 2022 - Regulatory reports |
Intoxicating hemp-derived cannabinoids (IHDC) have been major disruptors in the CBD and legal cannabis sectors in the US for some time now. This report details and analyses recent developments in their regulation
Intoxicating hemp products in the US – opportunity or risk?
20th December 2021 - Regulatory reports |
Some sellers of intoxicating cannabinoid products claim legality under the 2018 US Farm Bill. CBD-Intel believes that many hemp-derived cannabinoids do not violate federal controlled substance law
